• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antibiotic effects on bacterial profile in osteonecrosis of the jaw.抗生素对颌骨骨坏死中细菌谱的影响。
Oral Dis. 2012 Jan;18(1):85-95. doi: 10.1111/j.1601-0825.2011.01848.x. Epub 2011 Aug 29.
2
Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.口腔微生物组在颌骨样本中的分子剖析:双膦酸盐相关性颌骨骨坏死。
Oral Dis. 2012 Sep;18(6):602-12. doi: 10.1111/j.1601-0825.2012.01916.x. Epub 2012 Mar 23.
3
Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.口腔微生物群与双膦酸盐相关颌骨坏死中的宿主固有免疫反应。
Int J Oral Sci. 2014 Dec;6(4):219-26. doi: 10.1038/ijos.2014.46. Epub 2014 Aug 8.
4
Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics.接受全身性抗生素治疗的药物相关性颌骨坏死患者的微生物种群变化
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Mar;125(3):268-275. doi: 10.1016/j.oooo.2017.11.022. Epub 2017 Dec 11.
5
[A case report - bisphosphonate-related osteonecrosis of the jaw(stage 0)successfully treated with sitafloxacin].[一例报告——司帕沙星成功治疗双膦酸盐相关颌骨坏死(0期)]
Gan To Kagaku Ryoho. 2012 Dec;39(13):2573-5.
6
Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy.应用宏基因组学技术研究与双膦酸盐治疗相关的颌骨骨坏死患者的微生物和病毒。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Dec;114(6):764-70. doi: 10.1016/j.oooo.2012.08.444.
7
[Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces].[双膦酸盐相关颌骨骨坏死与放线菌感染]
Med Clin (Barc). 2012 Dec 15;139(15):676-80. doi: 10.1016/j.medcli.2012.05.039. Epub 2012 Oct 25.
8
Clinical experience with spiramycin in bisphosphonate-associated osteonecrosis of the jaw.螺旋霉素治疗双膦酸盐相关性颌骨骨坏死的临床经验。
Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):619-26. doi: 10.1177/039463201002300224.
9
Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws.40 例双膦酸盐相关性颌骨骨坏死患者的临床治疗效果。
J Formos Med Assoc. 2014 Mar;113(3):166-72. doi: 10.1016/j.jfma.2012.04.010. Epub 2012 Jul 31.
10
Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options.颌骨骨坏死与口腔微生物组:双膦酸盐相关性、临床危险因素、病理生理学和治疗选择。
Int J Mol Sci. 2024 Jul 24;25(15):8053. doi: 10.3390/ijms25158053.

引用本文的文献

1
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw.《中国颌骨药物相关性骨坏死诊断与临床治疗专家共识》
J Bone Oncol. 2024 Nov 19;49:100650. doi: 10.1016/j.jbo.2024.100650. eCollection 2024 Dec.
2
A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials.激光光生物调节剂量学与治疗方案在药物相关性颌骨坏死管理中的系统评价:对未来随机对照临床试验的合理共识
Pharmaceuticals (Basel). 2024 Jul 31;17(8):1011. doi: 10.3390/ph17081011.
3
Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options.颌骨骨坏死与口腔微生物组:双膦酸盐相关性、临床危险因素、病理生理学和治疗选择。
Int J Mol Sci. 2024 Jul 24;25(15):8053. doi: 10.3390/ijms25158053.
4
Dual-Functional Drug Delivery System for Bisphosphonate-Related Osteonecrosis Prevention and Its Bioinspired Releasing Model and In Vitro Assessment.用于预防双膦酸盐相关骨坏死的双功能药物递送系统及其仿生释放模型和体外评估
ACS Omega. 2023 Jul 14;8(29):26561-26576. doi: 10.1021/acsomega.3c03440. eCollection 2023 Jul 25.
5
Mechanistic advances in osteoporosis and anti-osteoporosis therapies.骨质疏松症及抗骨质疏松症治疗的机制进展
MedComm (2020). 2023 May 11;4(3):e244. doi: 10.1002/mco2.244. eCollection 2023 Jun.
6
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.颌骨骨坏死与良性及恶性疾病中的抗吸收药物:由 ECTS 组织的批判性回顾。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.
7
Schemes for Drug-Induced Treatment of Osteonecrosis of Jaws with Particular Emphasis on the Influence of Vitamin D on Therapeutic Effects.药物诱导治疗颌骨骨坏死的方案,特别强调维生素D对治疗效果的影响。
Pharmaceutics. 2021 Mar 8;13(3):354. doi: 10.3390/pharmaceutics13030354.
8
Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).光生物调节、手术治疗及抗生素疗法对药物相关性颌骨坏死(MRONJ)的互补作用
Medicina (Kaunas). 2021 Feb 5;57(2):145. doi: 10.3390/medicina57020145.
9
, and promote IL8/IFNγ/TNFα-based pro-inflammation in patients with medication-related osteonecrosis of the jaw.并且在药物相关性颌骨坏死患者中促进基于白细胞介素8/干扰素γ/肿瘤坏死因子α的促炎反应。
J Oral Microbiol. 2020 Nov 23;13(1):1851112. doi: 10.1080/20002297.2020.1851112.
10
Age-Associated Tooth Loss and Oral Microbial Dysbiosis in a Mouse Genetic Model of Chronic Nicotine Exposure.慢性尼古丁暴露小鼠遗传模型中的年龄相关性牙齿缺失和口腔微生物失调。
Front Immunol. 2020 Oct 7;11:575200. doi: 10.3389/fimmu.2020.575200. eCollection 2020.

本文引用的文献

1
WITHDRAWN: Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonisation.撤回:双膦酸盐通过促进细菌定植来引发颌骨坏死。
Med Hypotheses. 2011 Aug;77(2):214-5. doi: 10.1016/j.mehy.2011.04.015. Epub 2011 May 13.
2
Medical significance and new therapeutical strategies for biofilm associated infections.生物膜相关感染的医学意义及新治疗策略
Roum Arch Microbiol Immunol. 2010 Jul-Sep;69(3):125-38.
3
The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.骨质疏松症患者的面部骨骼:疾病体征与治疗并发症的一个领域。
J Osteoporos. 2011 Feb 16;2011:147689. doi: 10.4061/2011/147689.
4
Microbial diversity in saliva of oral squamous cell carcinoma.口腔鳞状细胞癌患者唾液中的微生物多样性
FEMS Immunol Med Microbiol. 2011 Apr;61(3):269-77. doi: 10.1111/j.1574-695X.2010.00773.x. Epub 2011 Feb 1.
5
Osteonecrosis of the jaw and the role of macrophages.颌骨骨坏死与巨噬细胞的作用。
J Natl Cancer Inst. 2011 Feb 2;103(3):232-40. doi: 10.1093/jnci/djq516. Epub 2010 Dec 28.
6
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw.延长术前抗生素治疗方案在双膦酸盐相关颌骨骨坏死治疗中的相关性。
J Oral Maxillofac Surg. 2011 Feb;69(2):362-80. doi: 10.1016/j.joms.2010.06.200. Epub 2010 Dec 3.
7
Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.双膦酸盐相关颌骨骨坏死的荧光引导下骨切除术:一项前瞻性初步研究的首个临床结果
J Oral Maxillofac Surg. 2011 Jan;69(1):84-91. doi: 10.1016/j.joms.2010.07.014. Epub 2010 Oct 25.
8
Bisphosphonate-related osteonecrosis of the jaw: an overview.双膦酸盐相关性颌骨坏死:概述。
Ann N Y Acad Sci. 2011 Feb;1218:38-46. doi: 10.1111/j.1749-6632.2010.05768.x. Epub 2010 Sep 28.
9
In vivo effects of zoledronic acid on oral mucosal epithelial cells.唑来膦酸对口腔黏膜上皮细胞的体内作用。
Oral Dis. 2011 Apr;17(3):291-7. doi: 10.1111/j.1601-0825.2010.01739.x. Epub 2010 Sep 23.
10
The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy.微生物生物膜在与双膦酸盐治疗相关的颌骨骨坏死中的作用。
Curr Osteoporos Rep. 2010 Mar;8(1):40-8. doi: 10.1007/s11914-010-0008-1.

抗生素对颌骨骨坏死中细菌谱的影响。

Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

机构信息

Department of Chemical and Biological Sciences, Polytechnic Institute of New York University, USA.

出版信息

Oral Dis. 2012 Jan;18(1):85-95. doi: 10.1111/j.1601-0825.2011.01848.x. Epub 2011 Aug 29.

DOI:10.1111/j.1601-0825.2011.01848.x
PMID:21883710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3232327/
Abstract

OBJECTIVE

Oral infection is considered to play a critical role in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (BRONJ), and antibiotic therapy has become a mainstay of BRONJ therapy. This study was aimed to investigate the effect of antibiotics on bacterial diversity in BRONJ tissues.

MATERIALS AND METHODS

The bacterial profile from soft tissues associated with the BRONJ lesion was determined using 16S rRNA-based denaturing gradient gel electrophoresis (DGGE) and sequencing. Twenty BRONJ subjects classified as stage 0-2 were enrolled in this study, and patient groups were divided into an antibiotic cohort (n=10) treated with systemic antibiotic and a non-antibiotic cohort (n=10) with no prior antibiotic therapy.

RESULTS

The DGGE fingerprints indicated no significant differences in bacterial diversity of BRONJ tissue samples. Patients on antibiotics had higher relative abundance of phylum Firmicutes with bacterial species, Streptococcus intermedius, Lactobacillus gasseri, Mogibacterium timidum, and Solobacterium moorei, whereas patients without antibiotics had greater amounts of Parvimonas micra and Streptococcus anginosus. Thirty percent of bacterial populations were uncultured (yet-to be cultured) phylotypes.

CONCLUSION

This study using limited sample size indicated that oral antibiotic therapy may have a limited efficacy on the bacterial population associated with BRONJ lesions.

摘要

目的

口腔感染被认为在双膦酸盐相关性颌骨骨坏死(BRONJ)的发病机制中起关键作用,抗生素治疗已成为 BRONJ 治疗的主要方法。本研究旨在探讨抗生素对 BRONJ 组织中细菌多样性的影响。

材料和方法

采用基于 16S rRNA 的变性梯度凝胶电泳(DGGE)和测序技术,确定与 BRONJ 病变相关的软组织中的细菌谱。本研究纳入了 20 名 BRONJ 患者(分期为 0-2 期),将患者分为抗生素组(n=10)和非抗生素组(n=10),抗生素组接受全身抗生素治疗,非抗生素组未接受过抗生素治疗。

结果

DGGE 指纹图谱表明 BRONJ 组织样本的细菌多样性无显著差异。使用抗生素的患者中厚壁菌门的相对丰度较高,细菌种类包括中间链球菌、加氏乳杆菌、迟缓真杆菌和摩氏摩根菌,而未使用抗生素的患者中普氏微菌和咽峡炎链球菌的数量较多。30%的细菌种群为未培养(尚未培养)的分类群。

结论

本研究使用有限的样本量表明,口腔抗生素治疗对 BRONJ 病变相关的细菌种群可能疗效有限。